Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Centrosomal protein 170B (CEP170B) is a structural protein encoded by the CEP170B gene, located on chromosome 14. It is a component of the centrosome, a non-membranous organelle that serves as the primary microtubule organizing center in animal cells. CEP170B is involved in the organization of microtubules, which is critical for cell structure and function, especially during cell division and mitotic spindle formation. It has been associated with rare inherited diseases such as hypogonadotropic hypogonadism with or without anosmia and primary autosomal recessive microcephaly, suggesting a potential role in neurological and reproductive development. No direct evidence indicates that CEP170B is a therapeutic drug target, nor are there known drugs, clinical biomarkers, or specific safety challenges directly associated with modulation of this protein in clinical settings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Centrosomal protein 170B (CEP170B).